DrugInformations.org

ORLANDO, FL (UroToday.com) - A common concern affecting most outcomes studies is the patients who are lost to follow up. Options include assuming they are failures, considering them successes, or disregarding their data, thereby effectively classifying them as equivalent to those who are followed up. Dr. Ballert and cohorts sought to answer the question of how these patients would be best classified. 60/213 patients who underwent a midurethral sling had

More: continued here

No Comments »

Consistently maintaining certain blood levels of markers of bone metabolism and disease can prolong the lives of patients on hemodialysis, according to a study appearing in the September 2008 issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that keeping parathyroid hormone, calcium, and phosphorous levels in control is critically important for dialysis patients with chronic kidney disease (CKD).

More: continued here

No Comments »

ORLANDO, FL (UroToday.com) - This study from from the UK may have put to rest the use of extracorporeal shock wave lithotripsy (ESWL) for the treatment of Peyronie’s Disease plaques. A prospective, randomized, double-blind trial that was designed to objectively assess the true effect of shock wave therapy (SWT) on PD. A total of 39 men were recruited for the trail, 19 men received SWT, 20 acted as controls. Each patient received 6 weekly treatments of either SWT or sham.

More: continued here

No Comments »

European Urology, the official journal of the European Association of Urology (EAU), has a newly released impact factor of 5.634. “The journal has been a respected urological forum for over 20 years and is currently read by more than 15,000 urologists across the globe,” Prof. Francesco Montorsi, Editor-in-Chief, points out. The Platinum Journal offers its readers and authors high quality papers, fast response and international profile.

More: continued here

No Comments »

ORLANDO, FL (UroToday.com) - The second session in trauma and reconstruction took place Saturday, May 17, 2008 and was moderated by Gerald Jordan and Jack McAninch. It consisted of 20 abstracts on topics ranging from blunt and penetrating urologic trauma, urethral reconstruction, management of pelvic fracture urethral defects, urethroplasty in transplant recipients, management of Urolume failures, and the use of bioengineered materials for urethral reconstruction.

More: continued here

No Comments »

ORLANDO, FL (UroToday.com) - The moderated poster session covering urodynamic testing covered a variety of subjects. Several abstracts focused on the assessment of bladder sensation and related afferent or autonomic actions. Tsang and colleagues (Abstract 1516) reported mapping studies using functional MRI during bladder filling in combination with urodynamic evaluation.

More: continued here

No Comments »

ORLANDO, FL (UroToday.com) - This presentation from Dr. Paulo Egydio, et al., from Serbia generated perhaps the most discussion of all of the abstracts at the session. This abstract dealt with the surgical treatment of severe Peyronie’s disease with circumferential tunical resection and grafting with cadaveric pericardium.

More: continued here

No Comments »

Prof. Peter Mulders from Nijmegen (NL) was recently appointed chairman of the executive board of the EAU Research Foundation (RF). The Clinical Studies Committee and the EAU Registries section are now headed by Profs. Anup Patel and Andrea Tubaro respectively. The foundation´s mission statement is ambitious and self-confident: “The EAU RF should be self-funded, so we should be successful in obtaining the money required,” chairman Peter Mulders pointed out.

More: continued here

No Comments »

ORLANDO, FL (UroToday.com) - Tolterodine and an alpha blocker provides superior relief from urgency and frequency compared to either medication alone. In addition, initial results from the ComBAT trial were presented. The combination of a 5-alpha reductase inhibitor and an alpha blocker is superior to either one alone at the 2 year mark. Tadalafil at either the 5, 10, or 20mg dose provides LUTS relief. On average, patients had a 4.0 to 5.0 point improvement in their AUASS.

More: continued here

No Comments »

ORLANDO, FL (UroToday.com) - The moderated poster session covering evaluation and therapy included a broad range of presentations. Several abstracts focused on the male sling for post-prostatectomy incontinence (PPI). Dr Walter and colleagues (Abstract 1497, data updated from publication) reported a series of 49 men undergoing AdVance sling for PPI. Post-operatively >85% of patients required 0-1 pads/day, with 24h pad weights improving from 264 to 44 grams.

More: continued here

No Comments »